Point of Care Coagulation Testing Devices Market to Grow with a CAGR of 5.79% through 2030
Technological
advancements in portable coagulation analyzers and increasing adoption in home
healthcare settings, is expected to drive the Global Point of Care
Coagulation Testing Devices Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Point of Care Coagulation Testing Devices Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Point of Care Coagulation Testing Devices
Market stood at USD 1.84
Billion in 2024 and is expected to reach USD 2.58 Billion by
2030 with a CAGR of 5.79% during the forecast period. The demand for point of care coagulation
testing devices is growing due to the increasing emphasis on preventive
healthcare and early diagnosis. Hospitals and ambulatory care units are under
constant pressure to improve patient throughput and reduce turnaround time,
which has accelerated the use of rapid diagnostic solutions.
Coagulation-related complications during surgeries, organ transplants, and
intensive care treatments require immediate assessment of clotting parameters.
Point of care devices allow clinicians to make real-time decisions during
procedures, which significantly improves patient safety and operational
efficiency.
The
industry is observing a shift in product design toward user-friendly, automated
systems capable of delivering lab-grade accuracy. Newer devices are designed to
function with minimal training, reducing dependency on skilled technicians. The
trend of integrating artificial intelligence and machine learning algorithms
for better interpretation of test results is also gaining traction. Compact
models are being launched to suit the demands of ambulatory surgery centers,
rural clinics, and military field operations. Battery-powered and
cartridge-based systems have improved the mobility and usability of these
devices. Demand from dialysis centers and oncology departments is on the rise,
as patients in these settings often require continuous monitoring of coagulation
parameters due to complex treatment regimens.
Emerging
markets present strong growth potential for point of care coagulation testing
devices. Rising healthcare infrastructure investments in countries across Asia,
Latin America, and the Middle East are expected to create favorable conditions
for adoption. Mobile health units and community-based clinics offer new
deployment opportunities in underserved areas. Partnerships between device
manufacturers and government health departments could further enhance reach and
affordability. Integration with telemedicine platforms is another area with
promise, enabling remote patient monitoring for those on long-term
anticoagulation therapy. As home-based healthcare models continue to evolve,
self-testing coagulation kits with digital support and video guidance could
become a mainstream offering in the near future.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Point of Care Coagulation Testing Devices Market”
The Global Point
of Care Coagulation Testing Devices Market is segmented into device type,
product, end user, regional distribution, and company.
Based on the Product,
Consumables & Accessories emerged as the fastest growing segment in the Global
Point of Care Coagulation Testing Devices Market during the forecast period. This growth is primarily driven by the
recurring demand for test strips, cartridges, reagents, and calibration
materials that are essential for the functioning of point of care coagulation
devices. As the adoption of these devices expands across hospitals, emergency
departments, homecare settings, and ambulatory clinics, the frequency of
testing increases, thereby driving up the consumption of associated
consumables. Each test performed requires a new set of consumables, making them
a continuous source of revenue for manufacturers. Moreover, with the rising
trend of home-based monitoring and self-testing, the demand for user-friendly
and pre-packaged consumables has surged.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Point of Care Coagulation Testing Devices Market during the forecast period. Technological advancements
tailored for emerging markets are fueling rapid growth in the Asia-Pacific
region. Several global and local manufacturers are launching compact,
affordable, and easy-to-use point of care coagulation testing devices
specifically designed for resource-limited settings. Battery-operated and
cartridge-based models that require minimal maintenance are gaining popularity
in remote and underserved areas. The growing penetration of private healthcare
providers and diagnostic chains is also expanding the reach of these devices
beyond metropolitan cities. In parallel, the adoption of digital health tools
such as mobile connectivity and telemedicine platforms is facilitating
real-time data sharing and remote patient monitoring, further driving demand.
Rising disposable incomes, improving insurance coverage, and increasing health consciousness
among the urban and semi-urban population are accelerating the shift toward
preventive healthcare and early diagnosis. These dynamic factors collectively
position Asia-Pacific as the fastest-growing market for point of care
coagulation testing devices throughout the forecast period.
Major
companies operating in Global Point of Care Coagulation Testing Devices
Market are:
- F.
Hoffmann-La Roche Ltd.
- Abbott
Laboratories
- Werfen,
S.A.
- Siemens
Healthineers
- Helena
Laboratories Corporation
- Medtronic
plc
- Koninklijke
Philips N.V.
- Alere
Inc.
- HemoSonics,
LLC
- Sysmex
Corporation
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Point of Care Coagulation
Testing Devices Market is expanding due to the growing adoption of connected
diagnostic solutions that allow real-time transmission of coagulation test
results to electronic health records and clinician dashboards. This
connectivity enhances clinical decision-making by enabling faster intervention,
especially in time-sensitive environments like emergency departments and
operating rooms. These digitally integrated systems support remote patient
monitoring and streamline communication between patients and healthcare
providers, making them particularly valuable in home care and telehealth
settings. As healthcare systems increasingly prioritize speed, accuracy, and
interoperability in diagnostics, the demand for smart coagulation devices
continues to rise”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Point of Care
Coagulation Testing Devices Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Device Type (Anticoagulation Monitoring
Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation
Monitoring Devices, Others), By Product (Instruments/Analyzers, Consumables
& Accessories), By End User (Hospitals, Clinics, Home Care Settings,
Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Point of Care Coagulation Testing Devices
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Point of Care
Coagulation Testing Devices Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com